IMPEL PHARMACEUTICALS INC: common_shares_outstanding
| Value | {"unit": "shares", "value": 22276271, "concept": "dei:EntityCommonStockSharesOutstanding"} |
|---|---|
| Period | (as of 2021-06-04) |
| Status | current |
| Entity | IMPEL PHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/7f7d87ee-eb40-4a3b-a90a-71dd9ae805db
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-21-000311 · Open the official SEC filing →Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001445499/common-shares-outstanding/2021-06-04 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/7f7d87ee-eb40-4a3b-a90a-71dd9ae805db
History
- no predecessors — first report